US FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics

US FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics

The U.S. Federal Trade Commission (FTC) has temporarily halted its opposition to Amgen’s $27.8 billion acquisition of Horizon Therapeutics, according to a filing on Friday. The suspension will allow the FTC to consider settling the case. The pause will remain in effect until September 18.

Amgen has acknowledged the FTC’s decision and is ready to demonstrate in court that there are no legal or factual grounds to block the acquisition. The company expressed its preference for honoring its commitment rather than going through a lengthy court process. Amgen expects to complete the acquisition by mid-December this year.

In an unusual move to block a major pharmaceutical deal, the FTC filed a lawsuit on May 16 against the transaction. The agency’s opposition to the deal stems from concerns that Amgen may use its best-selling drugs to pressure insurance companies and pharmacy benefit managers into providing favorable terms for Horizon’s key products, Tepezza and Krystexxa.

Amgen announced its intention to acquire Horizon in December of last year, citing the potential protection from drug pricing provisions offered by Horizon’s rare disease drugs. These provisions are aimed at drugs commonly used by the government’s Medicare health plan. The agency and Amgen are scheduled to meet in Chicago federal court in September to discuss the injunction.

Horizon Therapeutics has not yet responded to a request for comment from RushHourDaily.

Reporting by Urvi Dugar in Bengaluru; editing by Jason Neely and Diane Craft.

About News Team

Hi, I'm Alex Perez, an experienced writer with a focus on lifestyle and culture news. From food and fashion to travel and entertainment, I love exploring the latest trends and sharing my insights with readers. I also have a strong interest in world news and business, and enjoy covering breaking stories and events.

Have a tip we should know?

Most Read

  1. News
    Pandora Papers Financial Leak Shows Us the Secrets of the World’s Rich and Powerful
    3 years ago
  2. Health
    US Supreme Court Rejects J & J TALC Cancer Case Appeal
    3 years ago
  3. Lifestyle
    9 Habits that Drain your Daily Focus and How to Avoid Them
    3 years ago
    Women’s Demand for Shapewear – the big Trends
    3 years ago
    Valentino Launches its Cosmetics Line
    3 years ago
  6. Health
    US Promises to Share 60 million Doses of AstraZeneca Vaccines
    3 years ago
  7. Health
    UK Offers Aid Amid Surging COVID-19 Cases in India
    3 years ago
  8. Sports
    Thousands of fans welcome Charlton funeral cortege at Old Trafford
    7 months ago
  9. News
    Brit left fighting for life after train derails in Argentinia
    7 months ago
    Dubai faces down airline rivals with $50 bln jet orders
    7 months ago
  11. Sunak
    UK’s Sunak brings back Cameron, sacks Braverman
    7 months ago
  12. Sports
    Man United’s Hojlund, Eriksen withdrawn from Denmark team duty
    7 months ago
  13. Health
    Autumn Sneezing Syndrome is on the rise… here’s what you can do
    7 months ago
  14. Canada
    Canada beat Italy to win Billie Jean King Cup for first time
    7 months ago

Follow @rushhourdaily: